Analyst Consensus ?
ConsensusHold29 ratings
Bullish310.3%
Neutral2069.0%
Bearish620.7%
FN2 Earnings Intelligence
The Clorox Company complete analyst coverage
The Clorox Company (CLX) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$95.66Current
$83Low
$123.69Average
$185High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 31, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Jefferies | Hold | Buy | Downgrade | Jul 28, 2026 |
| Evercore ISI Group | Underperform | Underperform | Maintain | Jul 23, 2026 |
| Barclays | Underweight | Underweight | Maintain | Jul 21, 2026 |
| BNP Paribas | Neutral | Neutral | Maintain | Jul 20, 2026 |
| UBS | Neutral | Neutral | Maintain | Jul 16, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Jul 16, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | May 18, 2026 |
| Citigroup | Neutral | Neutral | Maintain | May 1, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Apr 23, 2026 |
| Deutsche Bank | Hold | Hold | Maintain | Mar 30, 2026 |
| TD Cowen | Hold | Hold | Maintain | Jan 8, 2026 |
| Goldman Sachs | Sell | Sell | Maintain | Jan 7, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 8, 2025 |
| DA Davidson | Neutral | Neutral | Maintain | Feb 5, 2025 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jan 30, 2025 |
| Bernstein | Market Perform | Underperform | Upgrade | Oct 12, 2023 |
| Raymond James | Market Perform | Outperform | Downgrade | Oct 5, 2023 |
| Atlantic Equities | Neutral | Underweight | Upgrade | Aug 3, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Nov 2, 2022 |
| Argus Research | Hold | Buy | Downgrade | Sep 3, 2021 |
| CFRA | Hold | Sell | Upgrade | Mar 4, 2020 |
| Bank of America | Neutral | Neutral | Maintain | Oct 3, 2019 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 2, 2018 |
| Argus | Buy | Hold | Upgrade | Sep 25, 2018 |
| B. Riley FBR | Sell | Neutral | Downgrade | May 5, 2018 |
| Sterne Agee CRT | Neutral | Buy | Downgrade | Feb 26, 2016 |
| Sterne Agee | Neutral | Buy | Downgrade | Feb 26, 2016 |
| B. Riley Securities | Neutral | Neutral | Maintain | Feb 9, 2016 |
| Wellington Shields | Buy | Hold | Upgrade | Mar 18, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $95.66. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Jefferies | Kaumil Gajrawala | $98 | $97.41 | +2.4% | Jul 28, 2026 |
| Evercore ISI | Javier Escalante | $98 | $93.62 | +2.4% | Jul 23, 2026 |
| Deutsche Bank | Analyst unavailable | $94 | $96.25 | -1.7% | Jul 22, 2026 |
| Morgan Stanley | Analyst unavailable | $97 | $88.25 | +1.4% | May 1, 2026 |
| Goldman Sachs | Bonnie Herzog | $83 | $87.73 | -13.2% | May 1, 2026 |
| Evercore ISI | Javier Escalante | $110 | $88.3 | +15.0% | May 1, 2026 |
| Deutsche Bank | Steve Powers | $91 | $96.44 | -4.9% | May 1, 2026 |
| UBS | Analyst unavailable | $96 | $96.44 | +0.4% | May 1, 2026 |
| Barclays | Analyst unavailable | $85 | $96.44 | -11.1% | May 1, 2026 |
| Jefferies | Kaumil Gajrawala | $139 | $100.34 | +45.3% | Apr 21, 2026 |
| RBC Capital | Analyst unavailable | $127 | $107.62 | +32.8% | Apr 9, 2026 |
| Wells Fargo | Analyst unavailable | $110 | $105.67 | +15.0% | Apr 8, 2026 |
| Wells Fargo | Chris Carey | $125 | $125.94 | +30.7% | Feb 17, 2026 |
| Redburn Partners | Analyst unavailable | $117 | $124.64 | +22.3% | Feb 13, 2026 |
| UBS | Peter Grom | $121 | $117.35 | +26.5% | Feb 4, 2026 |
| RBC Capital | Analyst unavailable | $132 | $116.62 | +38.0% | Feb 4, 2026 |
| Deutsche Bank | Analyst unavailable | $114 | $115.22 | +19.2% | Jan 23, 2026 |
| Wells Fargo | Analyst unavailable | $115 | $112.2 | +20.2% | Jan 23, 2026 |
| Barclays | Analyst unavailable | $109 | $109.26 | +13.9% | Jan 16, 2026 |
| UBS | Peter Grom | $115 | $110.64 | +20.2% | Jan 14, 2026 |
| Goldman Sachs | Analyst unavailable | $94 | $100.61 | -1.7% | Jan 7, 2026 |
| Wells Fargo | Analyst unavailable | $108 | $99.67 | +12.9% | Jan 5, 2026 |
| Morgan Stanley | Dara Mohsenian | $125 | $109.42 | +30.7% | Nov 4, 2025 |
| UBS | Peter Grom | $119 | $109.14 | +24.4% | Nov 4, 2025 |
| Wells Fargo | Analyst unavailable | $117 | $109.14 | +22.3% | Nov 4, 2025 |
| Jefferies | Kaumil Gajrawala | $152 | $109.14 | +58.9% | Nov 4, 2025 |
| UBS | Analyst unavailable | $128 | $118.82 | +33.8% | Oct 8, 2025 |
| Barclays | Analyst unavailable | $112 | $122.67 | +17.1% | Oct 1, 2025 |
| Barclays | Lauren Lieberman | $119 | $126.78 | +24.4% | Jul 15, 2025 |
| Barclays | Lauren Lieberman | $129 | $135.05 | +34.9% | May 7, 2025 |
| Evercore ISI | Javier Escalante | $140 | $135.05 | +46.4% | May 6, 2025 |
| Morgan Stanley | Dara Mohsenian | $150 | $135.05 | +56.8% | May 6, 2025 |
| Wells Fargo | Chris Carey | $142 | $133.64 | +48.4% | May 6, 2025 |
| Barclays | Lauren Lieberman | $139 | $145.63 | +45.3% | Mar 27, 2025 |
| Goldman Sachs | Bonnie Herzog | $132 | $159.56 | +38.0% | Oct 8, 2024 |
| Jefferies | Kaumil Gajrawala | $187 | $165.83 | +95.5% | Oct 1, 2024 |
| Barclays | Lauren Lieberman | $122 | $136.31 | +27.5% | Jul 19, 2024 |
| Wells Fargo | Chris Carey | $135 | $139.63 | +41.1% | May 2, 2024 |
| Jefferies | Kaumil Gajrawala | $145 | $150.52 | +51.6% | Mar 26, 2024 |
| RBC Capital | Nik Modi | $138 | $145.97 | +44.3% | Jan 30, 2024 |
| Raymond James | Olivia Tong | $185 | $124.69 | +93.4% | Oct 5, 2023 |
| J.P. Morgan | Ken Goldman | $153 | $155.1 | +59.9% | Sep 8, 2023 |
| Morgan Stanley | Analyst unavailable | $145 | $141 | +51.6% | Feb 3, 2023 |
| Raymond James | Analyst unavailable | $165 | $141 | +72.5% | Feb 3, 2023 |
| Jefferies | Analyst unavailable | $145 | $143.32 | +51.6% | Feb 1, 2023 |
| Wells Fargo | Analyst unavailable | $135 | $140.39 | +41.1% | Jan 3, 2023 |
| Deutsche Bank | Analyst unavailable | $151 | $146.7 | +57.9% | Dec 6, 2022 |
| Barclays | Analyst unavailable | $101 | $148.71 | +5.6% | Aug 19, 2022 |
| Raymond James | Olivia Tong | $160 | $143.89 | +67.3% | Jul 12, 2022 |
| D.A. Davidson | Analyst unavailable | $123 | $147.56 | +28.6% | May 3, 2022 |
| Morgan Stanley | Analyst unavailable | $137 | $143.28 | +43.2% | May 3, 2022 |
| Wells Fargo | Analyst unavailable | $130 | $143.28 | +35.9% | May 3, 2022 |
| Barclays | Lauren Lieberman | $117 | $148.34 | +22.3% | Apr 29, 2022 |
| Deutsche Bank | Steve Powers | $146 | $150.65 | +52.6% | Apr 24, 2022 |
| D.A. Davidson | Linda Bolton Weiser | $127 | $143.22 | +32.8% | Feb 8, 2022 |
| UBS | Peter Grom | $148 | $141.41 | +54.7% | Feb 4, 2022 |
| Bernstein | Callum Elliott | $155 | $166.99 | +62.0% | Feb 2, 2022 |
| Credit Suisse | Kaumil Gajrawala | $160 | $164.72 | +67.3% | Jan 26, 2022 |
| Jefferies | Kevin Grundy | $185 | $176.27 | +93.4% | Jan 5, 2022 |
Track every rating change on CLX the moment it posts. Free to start.
Start free